Pneumonia, Pneumocystis: all 106 studies

Page 1 of 2. Open to participants first (15), then studies with results posted, then the rest; newest registration first within each.

• Derivation and Validation of the Fungal Pneumonia Assessment and Likelihood Predictor ScoreRecruitingNCT07681583
• Low- vs Standard-Dose TMP-SMX for Prevention of Pneumocystis Pneumonia After Kidney TransplantationNot yet recruitingNCT07619027Phase 4
• Positioning Second-line Therapies for Pneumocystis Jirovecii Pneumonia (PCP Alternatives)Not yet recruitingNCT07357103Phase 4
• How Long Should we Give Steroids for Patients With Severe PCPNot yet recruitingNCT07328984Phase 4
• Introduction of Polymerase Chain Reaction (PCR) in Microbiology and ParasitologyRecruitingNCT07269314
• Corticosteroids for PJP in Non-HIV Immunocompromised AdultsNot yet recruitingNCT07152613Phase 3
• CaspoNEB: Efficacy and Safety of Caspofungin Aerosols for the Curative Treatment of Pneumocystis PneumoniaRecruitingNCT06892951Phase 1/2
• Optimizing the Diagnosis of Pneumocystis in Immunocompromised PatientsRecruitingNCT06890078
• Caspofungin for Pneumocystis Pneumonia in PLWHIV.RecruitingNCT06691321
• Efficacy and Safety of Prophylactic Treatment for Pneumocystis Jirovecii Pneumonia in Patients With Autoimmune Inflammatory Rheumatic DiseaseRecruitingNCT06499233Phase 4
• Pneumocystis Jirovecii GenotypingNot yet recruitingNCT06442345
• Factors Associated With Survival in Patients Having Pneumocystis JiroveciiRecruitingNCT06173453
• Rezafungin for Treatment of Pneumocystis Pneumonia in HIV AdultsRecruitingNCT05835479Phase 2
• Low Dose Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis Jirovecii PneumoniaRecruitingNCT04851015Phase 3
• Short-term Steroid Therapy in Patients With P. Jirovecii Pneumonia Due to HIV / AIDSEnrolling by invitationNCT03856229Not applicable
• Treatment of Pneumocystis in COPD (the TOPIC Study)TerminatedNCT05418777Phase 1/2Results posted
• Daily Isoniazid to Prevent Tuberculosis in Infants Born to Mothers With HIVTerminatedNCT00080119Phase 2/3Results posted
• Performance Evaluation of the Fujifilm Wako Beta-D-glucan Technique in the Diagnosis of Major Invasive Fungal Infections (IFI)CompletedNCT07272915
• Pneumocystis in Patients Over 75 YearCompletedNCT07004127
• Assessing Diagnostic Methods for Invasive Fungal Disease in Lung Transplant RecipientsCompletedNCT06654076
• Droplet Digital PCR and PCR-free BIOSensors for the Detection of Resistance-associated SNPs in Pneumocystis JiroveciiActive, not recruitingNCT06431958
• Prospective Observational Study on the Incidence of Opportunistic Fungal InfectionsCompletedNCT05707156
• Radiomics Model for the Diagnosis of Pneumocystis Jirovecii Pneumonia in Non-HIV PatientsStatus unknownNCT05701631
• PCP in Immunocompromised Population in Southern ChinaStatus unknownNCT05605145
• Pneumocystis Jirovecii Pneumonia in Non-HIV-infected Immunocompromised PatientsCompletedNCT05458752
• A Case-control Study on Risk Factors, Timing, and PCR Use, for Pneumocystis Pneumonia (PcP) After Allogeneic HSCTCompletedNCT05077150
• Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow TransplantationCompletedNCT04368559Phase 3
• Non-invasive Diagnosis of Invasive Pulmonary Aspergillosis by Use of Biomarkers in Exhaled Breath CondensateCompletedNCT04358419
• Clindamycin-trimethoprim/Sulfamethoxazole for PCP After Solid Organ Transplantation Population.CompletedNCT04328688
• Efficacy and Safety of Hydroxychloroquine for Treatment of COVID-19CompletedNCT04261517Phase 3
• Efficacy and Safety of Darunavir and Cobicistat for Treatment of COVID-19Status unknownNCT04252274Phase 3
• Trimethoprim/Sulfamethoxazole Combined With Caspofungin as First-line Therapy in PCPStatus unknownNCT03978559Phase 4
• Pneumocystis Primary Infection in Non-immunosuppressed InfantsCompletedNCT03740646
• Granulomatous Pneumocystis PneumoniaCompletedNCT03731156
• Non Invasive Diagnosis of Pneumocystis PneumoniaCompletedNCT03613025Not applicable
• Specialized Proresolving Mediators in Pneumocystis Jirovecii PneumoniaCompletedNCT03606252Not applicable
• Spirulina Supplementation and Infant Growth, Morbidity and Motor DevelopmentCompletedNCT03523182Not applicable
• Prospective Registration of Severe Pneumocystis Jiroveci Pneumonia Requiring ICU AdmissionStatus unknownNCT03201497
• Impact of Cotrimoxazole Use in Immunocompetent HIV Patients on Carriage of Antimicrobial Resistant BacteriaCompletedNCT03087890Phase 4
• Effect of Steroids During Pneumocystis Infection Among Non HIV Immunocompromised PatientsStatus unknownNCT02944045Phase 3
• Intravenous Pentamidine for Pneumocystis Jirovecii PneumoniaCompletedNCT02669706
• Pneumocystis Pneumonia Diagnosis in HIV- PatientsCompletedNCT02648256Not applicable
• Effects and Safety of Caspofungin and Corticosteroids in Pneumocystis Pneumonia in Non-HIV PatientsStatus unknownNCT02603575Not applicable
• Clinical Utility Of Genetic Screening For HLA-B*1301, On Susceptibility To Dapsone Hypersensitivity SyndromeStatus unknownNCT02550080Phase 4
• Pneumocystis Jerovici Pneumonia in Infants and SteroidsCompletedNCT02149433Not applicable
• Assessment of CMV-specific ELISPOT Assay for Predicting CMV Co-infection in Patients With Pneumocystitis Pneumonia (ACE-PCP)CompletedNCT02109887
• A Pharmacokinetic and Pharmacogenetic Study in Patients Receiving Sulfamethoxazole-trimethoprim TherapyStatus unknownNCT02045160
• Study of Trimethoprim/Sulfamethoxazole as PCP Prophylaxis in CTD PatientsStatus unknownNCT01747278Phase 2/3
• Prevalence of Pneumocystis Jirovecii and of Cytomegalovirus in Bronchial Wash Fluid of Patients Undergoing BronchoscopyCompletedNCT01395498
• Prevalence and Pathogenesis of Lung Disease in a Large HIV Cohort-coordinating CenterCompletedNCT00870857
• Pneumocystis in Pathogenesis of HIV-associated EmphysemaCompletedNCT00869544
• Corticosteroids Therapy and Pneumocystis Jirovecii Pneumonia (PCP)WithdrawnNCT00636935Phase 4
• Occurrence of Pneumocystis Pneumonia in HIV-Infected Patients and the Interference of the HAARTCompletedNCT00516581
• New Techniques for Using a Saline Wash as a Diagnostic Tool for Pneumocystis PneumoniaCompletedNCT00342589
• DB289 Versus TMP-SMX for the Treatment of Acute Pneumocystis Jiroveci Pneumonia (PCP)TerminatedNCT00302341Phase 3
• A Comparison of HIV-Infected Patients With and Without Opportunistic (AIDS-Related) InfectionCompletedNCT00005572
• A Study of Neutrexin Plus Leucovorin in the Treatment of Pneumocystis Carinii Pneumonia (PCP)CompletedNCT00002434Not applicable
• A Comparison of Atovaquone and Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia in HIV-Infected Patients Who Cannot Take TMP/SMXCompletedNCT00002340Phase 3
• A Study of Trimetrexate Plus Leucovorin in Children With Pneumocystis Carinii PneumoniaCompletedNCT00002317Not applicable
• A Study of Two Forms of Pentamidine in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDSCompletedNCT00002292Not applicable
• The Safety and Effectiveness of Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS Who Have Had PCP BeforeCompletedNCT00002291Not applicable
• A Comparison of Dapsone and Trimethoprim-Sulfamethoxazole in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDSCompletedNCT00002283Not applicable
• A Comparison of Two Types of Injected Nutritional Supplements in Patients With AIDS and Pneumocystis Carinii Pneumonia (PCP)CompletedNCT00002275Not applicable
• Randomized Phase I Study of Trimetrexate Glucuronate (TMTX) With Leucovorin (LCV) Protection Plus Dapsone Versus Trimethoprim / Sulfamethoxazole (TMP/SMX) for Treatment of Moderately Severe Episodes of Pneumocystis Carinii PneumoniaCompletedNCT00002120Phase 1
• A Compassionate Treatment Protocol for the Use of Trimetrexate Glucuronate (Neutrexin) With Leucovorin Protection for European Adult Patients (>= 13 Years Old) With Pneumocystis Carinii PneumoniaCompletedNCT00002103Not applicable
• A Compassionate Treatment Protocol for the Use of Trimetrexate Glucuronate With Leucovorin Protection for Patients With Pneumocystis Carinii Pneumonia.CompletedNCT00002102Not applicable
• A Controlled Trial Comparing the Efficacy of Aerosolized Pentamidine and Parenteral / Oral Trimethoprim - Sulfamethoxazole in the Treatment of Pneumocystis Carinii Pneumonia in AIDSCompletedNCT00002056Not applicable
• A Double-Blind Group Comparative Study To Evaluate the Long-Term Safety and Effectiveness of Two Different Doses of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients With Multiple Episodes of PCPCompletedNCT00002055Not applicable
• A Double-Blind Study To Evaluate the Long-Term Safety and Effectiveness of 60 mg Versus 120 mg of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS PatientsCompletedNCT00002054Not applicable
• A Double-Blind Placebo-Controlled Group Comparative Study To Evaluate the Safety and Effectiveness of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in Patients With AIDS Post First Episode PCPCompletedNCT00002053Not applicable
• Dapsone 100 Mg Versus 50 as Primary Prophylaxis for Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS-Related Complex (ARC)CompletedNCT00002043Not applicable
• An Open Label Study to Evaluate the Long-Term Safety and Effectiveness of Aerosol Pentamidine in the Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS PatientsCompletedNCT00002030Not applicable
• A Randomized, Double-Blind, Placebo Controlled Study of l-Leucovorin in Combination With Trimethoprim / Sulfamethoxazole in the Therapy of Pneumocystis Carinii Pneumonia in Patients With the Acquired Immunodeficiency SyndromeCompletedNCT00002002Not applicable
• A Phase II Open Randomized Comparison of 566C80 and Pentamidine Isethionate for the Treatment of Pneumocystis Carinii Pneumonia in AIDS Patients Who Are Intolerant of Trimethoprim / SulfamethoxazoleCompletedNCT00001996Phase 2
• A Treatment IND for 566C80 Therapy of Pneumocystis Carinii PneumoniaCompletedNCT00001991Not applicable
• An Open-Label, Uncontrolled Clinical Trial of Oral 566C80 for the Treatment of Patients With Severe PCP Who Are Intolerant and/or Unresponsive to Therapy With Trimethoprim/Sulfamethoxazole and Parenteral PentamidineCompletedNCT00001990Not applicable
• A Study of Pentamidine Plus Dapsone in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Patients Who Cannot Take Trimethoprim or SulfonamidesCompletedNCT00001028Phase 3
• A Study of Pentamidine in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Children Who Cannot Take Trimethoprim-SulfamethoxazoleCompletedNCT00001027Phase 1
• A Treatment Protocol for the Use of Trimetrexate With Leucovorin Rescue for AIDS Patients With Pneumocystis Carinii Pneumonia and Serious Intolerance to Approved TherapiesCompletedNCT00001016Phase 3
• Trimetrexate Plus Leucovorin Calcium Rescue Versus Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDSCompletedNCT00001014Phase 3
• Comparison of Trimetrexate Plus Leucovorin Calcium Rescue Versus Sulfamethoxazole-Trimethoprim in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDSCompletedNCT00001013Phase 3
• A Study of Pentamidine in the Prevention of Pneumocystis Carinii PneumoniaCompletedNCT00001003Not applicable
• A Study of Trimetrexate in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS Not Previously Treated for PCPCompletedNCT00000998Phase 1
• A Study of Three Drugs Plus Zidovudine in the Prevention of Infections in HIV-Infected PatientsCompletedNCT00000991Phase 3
• A Study of Two Forms of Pentamidine in HIV-Infected Children Who May Have Pneumocystis Carinii PneumoniaCompletedNCT00000974Phase 1
• A Study to Evaluate the Impact of Stopping Treatment for the Prevention of Pneumonia in HIV-Positive Patients Receiving Anti-HIV Drugs Who Have Increased CD4 Cell CountsCompletedNCT00000908
• A Study of WR 6026 in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected PatientsCompletedNCT00000863Phase 2
• Gradual Initiation of Sulfamethoxazole/Trimethoprim as Primary Pneumocystis Carinii Pneumonia ProphylaxisCompletedNCT00000816Phase 4
• A Study to Compare Different Drugs Used to Prevent Serious Bacterial Infections in HIV-Positive ChildrenCompletedNCT00000811Phase 2
• A Randomized, Comparative Study of Daily Dapsone and Daily Atovaquone for Prophylaxis Against PCP in HIV-Infected Patients Who Are Intolerant of Trimethoprim and/or SulfonamidesCompletedNCT00000802Phase 3
• A Study of Psychosocial and Behavioral Determinants of Differential Rates of Participant Compliance in CPCRA ProtocolsCompletedNCT00000784
• Phase I Safety and Pharmacokinetics Study of Microparticulate Atovaquone (m-Atovaquone; 566C80) in HIV-Infected and Perinatally Exposed Infants and ChildrenCompletedNCT00000773Phase 1
• A Randomized, Comparative, Prospective Study of Daily Trimethoprim / Sulfamethoxazole (TMS) and Thrice-Weekly TMS for Prophylaxis Against PCP in HIV-Infected PatientsCompletedNCT00000748Phase 3
• The Safety and Effectiveness of Methylprednisolone in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Children With AIDSWithdrawnNCT00000741Phase 3
• Escalating Multiple-Dose Safety and Tolerance of WR 6026 Hydrochloride in HIV-Infected SubjectsCompletedNCT00000740Phase 1
• Comparison of Two Dosage Regimens of Oral Dapsone for Prophylaxis of Pneumocystis Carinii Pneumonia in Pediatric HIV InfectionCompletedNCT00000739Phase 1
• Comparison of Three Treatments for Pneumocystis Pneumonia in AIDS PatientsTerminatedNCT00000730Phase 3
• A Controlled Comparative Trial of Sulfamethoxazole-Trimethoprim Versus Aerosolized Pentamidine for Secondary Prophylaxis of Pneumocystis Carinii Pneumonia in AIDS Patients Receiving Azidothymidine (AZT)CompletedNCT00000727Phase 3
• A Study of Trimetrexate With Leucovorin Rescue for AIDS Patients Who Are Refractory to Standard Therapies for Pneumocystis Carinii PneumoniaCompletedNCT00000724Phase 3
• Aerosols in the Treatment of Pneumocystis Pneumonia: A Pilot Study Quantitating the Deposition of Aerosolized Pentamidine as Delivered in ACTG 040 and Comparing Its Toxicity With Parenteral Pentamidine TherapyCompletedNCT00000722Not applicable

← Pneumonia, Pneumocystis overview